Working smarter not harder: Coupling implementation to de-implementation

Healthcare

Volumn 6, Issue 2, 2018, Pages 104-107

  Wang, Virginia ^a,b   Maciejewski, Matthew L ^a,b,f   Helfrich, Christian D ^c,d   Weiner, Bryan J ^d,e  

^a DURHAM VA HEALTH CARE SYSTEM   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f DURHAM VA MEDICAL CENTER   (United States)

Author keywords

De implementation; Learning; Organizational change; Unlearning

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DE IMPLEMENTATION; EVIDENCE BASED PRACTICE; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HUMAN; LEARNING; PHYSICIAN; TREATMENT WITHDRAWAL; HEALTH CARE DELIVERY; ORGANIZATION; POLICY; PROCEDURES;

DELIVERY OF HEALTH CARE; HUMANS; LEARNING; ORGANIZATIONAL INNOVATION; POLICY;

EID: 85039745439     PISSN: 22130764     EISSN: 22130772     Source Type: Journal    
DOI: 10.1016/j.hjdsi.2017.12.004     Document Type: Article

References (24)

1. van Bodegom-Vos, L., Davidoff, F., Marang-van de Mheen, P.J., Implementation and de-implementation: two sides of the same coin?. BMJ Qual Saf 26:6 (2017), 495–501.
2. Siu, A.L., Force USPST, Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 164:4 (2016), 279–296.
3. Moyer, V.A., Force USPST, Screening for cervical cancer: u.s. Preventive Services Task Force recommendation statement. Ann Intern Med 156:12 (2012), 880–891 [W312].
4. Pogach, L., Tseng, C.L., Soroka, O., Maney, M., Aron, D., A proposal for an out-of-range glycemic population health safety measure for older adults with diabetes. Diabetes care 40:4 (2017), 518–525.
5. American College of O, Gynecologists’ Committee on Practice B-O. Practice Bulletin No. 165: Prevention and Management of Obstetric Lacerations at Vaginal Delivery. Obstetrics and gynecology. 2016;128(1):e1–e15.
6. Moyer, V.A., Force USPST, Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 158:1 (2013), 47–54.
7. American Board of Internal Medicine (ABIM) Foundation CW. American College of Cardiology: Electrocardiography pre-operative screening; 2017. 〈http://www.choosingwisely.org/clinician-lists/acc-ecg-pre-op-screening/〉.
8. Fleisher, L.A., Fleischmann, K.E., Auerbach, A.D., et al. ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. [2014] J Am Coll Cardiol 64:22 (2014), e77–137.
9. Diette, G.B., Orr, P., McCormack, M.C., Gandy, W., Hamar, B., Is pharmacologic care of chronic obstructive pulmonary disease consistent with the guidelines?. Popul Health Manag 13:1 (2010), 21–26.
10. Franssen, F.M., Spruit, M.A., Wouters, E.F., Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 6 (2011), 493–501.
11. Jolly, S.S., Yusuf, S., Cairns, J., et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 377:9775 (2011), 1409–1420.
12. Lipska, K.J., Yao, X., Herrin, J., et al. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013. Diabetes Care 40:4 (2017), 468–475.
13. Searle, A., Spink, M., Ho, A., Chuter, V., Exercise interventions for the treatment of chronic low back pain: a systematic review and meta-analysis of randomised controlled trials. Clin Rehabil 29:12 (2015), 1155–1167.
14. van Tulder, M.W., Koes, B.W., Bouter, L.M., Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions. Spine 22:18 (1997), 2128–2156.
15. Desai, N.R., Bradley, S.M., Parzynski, C.S., et al. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention. JAMA 314:19 (2015), 2045–2053.
16. Fihn, S.D., Blankenship, J.C., Alexander, K.P., et al. ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. [2014] Circulation 130:19 (2014), 1749–1767.
17. Bonchek, M., Why the Problem with Learning Is Unlearning. 2016, Harvard Business Review.
18. Tsang, E.W., Zahra, S.A., Organizational unlearning. Human Relat 61:10 (2008), 1435–1462.
19. Bero, L.A., Grilli, R., Grimshaw, J.M., Harvey, E., Oxman, A.D., Thomson, M.A., Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ 317:7156 (1998), 465–468.
20. Davey, P., Brown, E., Charani, E., et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev(4), 2013, CD003543.
21. Jenkins, H.J., Hancock, M.J., French, S.D., Maher, C.G., Engel, R.M., Magnussen, J.S., Effectiveness of interventions designed to reduce the use of imaging for low-back pain: a systematic review. CMAJ 187:6 (2015), 401–408.
22. Brookhart, M.A., Schneeweiss, S., Avorn, J., Bradbury, B.D., Liu, J., Winkelmayer, W.C., Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA 303:9 (2010), 857–864.
23. Swaminathan, S., Mor, V., Mehrotra, R., Trivedi, A.N., Effect of medicare dialysis payment reform on use of erythropoiesis stimulating agents. Health Serv Res 50:3 (2015), 790–808.
24. Wang, C., Kane, R., Levenson, M., et al. Association between changes in CMS reimbursement policy and drug labels for erythrocyte-stimulating agents with outcomes for older patients undergoing hemodialysis covered by fee-for-service medicare. JAMA Intern Med 176:12 (2016), 1818–1825.